User Name Password

back to homepage

Selwyn Resources (SWN.V) - valuation improves despite unfavourable moves in metal prices

Update by Objective Capital , Aug 03, 2010 (login for full report)
Click for previous reports on this company
Questions? Contact our analyst

Key Points:

  • Selwyn is poised to close its joint venture with Yunnan Chihong
    Selwyn Resources anticipates closing its joint venture with Yunnan Chihong Zinc and Germanium in August. Under the proposed terms of the arrangement, Selwyn Resources will transfer title to the property to a new entity, Selwyn Chihong Mining Ltd (SCML). In return, Yunnan Chihong will contribute C$100m to SCML. Selwyn and Yunnan Chihong will each own a 50-percent interest in SCML. Further, Selwyn Resources anticipates receiving approximately C$9m as reimbursement of project expenses since July, 2009.

  • A full feasibility study is under way at Selwyn
    Selwyn has engaged Wardrop to conduct further work and exploration at the Selwyn project. This programme is expected to lead to a NI 43-101-compliant feasibility study that should be complete Q2 2011. The move to full feasibility results in increased confidence for a favourable production decision, and hence an improved valuation.

  • Metallurgical testing has improved expectations for metal recoveries
    Selwyn engaged G&T Metallurgical Services to conduct further metallurgical testing, which was completed this spring. Processing of a 6.6-tonne batch of high-grade material taken from the XY Central zone resulted in increased recovery rates for both zinc and lead. Based on this work, we have increased our expected recovery rate for zinc from 83 percent to 85 percent, and for lead from 65 percent to 69 percent. This in turn results in a significant increase in our valuation.

  • Decreased metals prices have a modest negative impact on our valuation
    Since our initiation note of March 2010, prices of both zinc and lead have declined by over 10 percent. Nevertheless, our model anticipates little long run change in prices from values contained in our initiation note. The Canadian dollar has strengthened by approximately 5 percent against the U.S. dollar, which decreases anticipated revenues by a comparable amount. These changes only partially counter the increase in revenues anticipated from the higher metal recovery rates.

  • Our basic mine model remains unchanged
    We continue to hypothesise a Selwyn mine will draw upon nearly 50 million tonnes of mineralisation averaging 9.4 percent zinc and 3.3 percent lead. We anticipate mining will commence in late 2014 with a milling capacity of 8,000 tonnes per day. We further assume capital spending will commence in late 2011 and will total C$850m. Our anticipated operating costs are C$60 per tonne initially, escalating for inflation at a nominal rate thereafter.

  • Our valuation of Selwyn Resources increases to C$0.43 per share
    Based on recent developments, our base-case valuation of Selwyn Resources increases from C$0.34 per share to C$0.43 per share. Our more optimistic assessment, based on higher confidences of exploration success, increases to C$0.74 per share. Assuming success at all stages through feasibility and permitting, our base-case and optimistic assessments increase to C$1.19 and C$1.93 per share respectively.

Free registration required for full report

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer